Publication:
Molecular cytogenetic characterization of rhabdomyosarcoma cell lines.

dc.contributor.authorRodriguez Perales, Sandra
dc.contributor.authorMartínez-Ramírez, Angel
dc.contributor.authorde Andrés, Sara Alvarez
dc.contributor.authorValle, Laura
dc.contributor.authorUrioste, Miguel
dc.contributor.authorBenítez, Javier
dc.contributor.authorCigudosa, Juan C
dc.date.accessioned2025-02-03T06:48:34Z
dc.date.available2025-02-03T06:48:34Z
dc.date.issued2004-01-01
dc.description.abstractAlveolar rhabdomyosarcomas (ARMS) are soft-tissue tumors that are genetically characterized by the presence of reciprocal translocations that generate the fusion gene PAX3-FOXO1A or PAX7-FOXO1A. For the study of the biologic consequences of such rearrangements, several cell lines have been generated. However, established cell lines accumulate chromosome and genetic aberrations that make it difficult to draw significant conclusions. We have applied a set of techniques that includes spectral karyotyping, fluorescence in situ hybridization (FISH), comparative genomic hybridization (CGH), and microarray CGH, to the most commonly used cell lines carrying the two fusion genes that are present in ARMS. We have identified the bacterial artificial chromosomes that cover the breakpoints at genes PAX3, PAX7, and FOXO1A, which can be used as FISH probes for the translocations. The RH30 cell line, positive for the PAX3-FOXO1A fusion gene, was found to be highly complex: wide range of chromosome number, more than 50 chromosome rearrangements, amplification of the hybrid gene, 24 DNA changes detected by conventional CGH, and 21 gene copy changes detected by microarray CGH (including several high-level amplifications). RMZ-RC2 cell line, positive for the PAX7-FOXO1A, was in the near-tetraploid range with only nonclonal structural rearrangements, amplification of the hybrid gene, 24 DNA changes by CGH, and 8 gene copy changes, confirming the previously reported high-level amplification of MYCN.
dc.format.number1
dc.format.page35-43
dc.format.volume148
dc.identifier.citationCancer Genet Cytogenet . 2004 Jan 1;148(1):35-43.
dc.identifier.journalCancer Genet Cytogenet
dc.identifier.pubmedID14697639
dc.identifier.urihttps://hdl.handle.net/20.500.12105/26234
dc.language.isoeng
dc.publisherElsevier
dc.relation.publisherversionhttps://doi: 10.1016/s0165-4608(03)00216-4.
dc.repisalud.institucionCNIO
dc.repisalud.orgCNIOCNIO::Unidades técnicas::Unidad de Citogenética Molecular
dc.rights.accessRightsopen access
dc.rights.licenseAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectCOMPARATIVE GENOMIC HYBRIDIZATION
dc.subjectALVEOLAR RHABDOMYOSARCOMA
dc.subjectHUMAN SARCOMAS
dc.subjectFUSION GENES
dc.subjectAMPLIFICATION
dc.subjectPAX7-FKHR
dc.subjectEXPRESSION
dc.subjectPAX3-FKH3
dc.subjectTUMORS
dc.titleMolecular cytogenetic characterization of rhabdomyosarcoma cell lines.
dc.typeresearch article
dc.type.hasVersionAM
dspace.entity.typePublication
relation.isAuthorOfPublicationcac6c6e2-06a9-4548-b216-3d7d32ed6b6e
relation.isAuthorOfPublication.latestForDiscoverycac6c6e2-06a9-4548-b216-3d7d32ed6b6e

Files

Original bundle

Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
molecularcytogenetic-2004.pdf
Size:
513.06 KB
Format:
Adobe Portable Document Format
Loading...
Thumbnail Image
Name:
Carátula repisalud.docx
Size:
42.85 KB
Format:
Microsoft Word XML